NOV 13, 2018 7:34 PM PST

Yin & Yang: The Duality of Cancer-Associated Fibroblasts in Pancreatic Cancer

Pancreatic Cancer is a devastating disease. This year alone, fifty-five thousand new patients were diagnosed in the United States (1). Unfortunately, not only is it painful, but it is usually diagnosed too late for effective treatment with currently available therapies. Researchers in the Tuveson Lab at Cold Spring Harbor Laboratory are hoping to change the fate of those diagnosed with pancreatic cancer by targeting the cancer-associated fibroblasts (CAFs) that support tumor growth.

Pancreatic cancer cells (red) surrounded by a vast stroma (cyan). Nuclei are in blue, and this image was created by Neelima Shah and Edna Cukierman.

Pancreatic Ductal Adenocarcinoma (PDAC), the most common type of pancreatic cancer, has a 1-year survival rate of 20% and a 5-year survival rate of less than half that (2). Prognosis is so poor because treatment is complicated by the lack of blood vessels in the tumor and the high rate of metastasis. Without a blood supply, chemotherapies can’t reach or target cancerous cells, and PDAC’s location near ducts allows cancerous cells to slough off and establish satellite tumors at other locations.

Like all solid tumors, PDAC is made up of both cancerous cells and a support system, the stroma (3). However, PDAC is unique in that close to 90 percent of the tumor mass is stroma, and it is in the stroma that CAFs secrete factors that promote tumor progression and metastasis. (4).

Previously, CAFs were found to be pro-tumorigenic. However, studies and clinical trials designed to target CAFs failed to inhibit the progression of PDAC, and in some cases exacerbated it (Biffi et al). This suggests that there must be heterogeneity in the CAF population which is exactly what Biffi et al saw. They demonstrated that PDAC stroma contains two subsets of CAFs, one inflammatory (iCAF) located close to the cancerous cells, and the other myofibroblastic (myCAF) located more distally.

In this study, they built on that observation and determined the factors which control the differentiation of each type of CAF. Following single-cell RNA sequencing of both iCAFs and myCAFs, they used biochemistry and learned that while IL-1 signaling turns on pathways in CAF precursors that cause differentiation into iCAFs, TGF-β downregulates the IL-1 receptor (IL-1R) resulting in those precursors adopting a myofibroblastic phenotype (myCAFs).

But they didn’t stop there. Using a mouse model that recapitulates PDAC, they inhibited signaling downstream of the IL-1R and not only saw a significant reduction in tumor burden, but the small, remaining tumors contained more tumor suppressive myofibroblastic CAFs.

So, the previous clinical trials that inhibited CAFs may have failed because they inhibited both the inflammatory iCAFs and the tumor-suppressive myCAFs. It is possible that by specifically targeting iCAFs in patients’ pancreatic cancers, a diagnosis of pancreatic cancer will no longer be a death sentence.

Learn more about cancer-associated fibroblasts from the video

 

Sources: 1) cancer.org; 2) pancreatic.org; 3) Journal of Thoracic Oncology; 4) Genes & Diseases; 5) Journal of Experimental Medicine

About the Author
  • Aleishia is a freelance medical/science writer that specializes in research-oriented content. Contact her for work.
You May Also Like
JUL 27, 2020
Cell & Molecular Biology
White Blood Cells Are Essential to the Developing Brain
JUL 27, 2020
White Blood Cells Are Essential to the Developing Brain
The brain is protected by a protective shield called the blood-brain barrier, which only allows certain things to pass t ...
AUG 24, 2020
Immunology
Injectable Drug Stops HIV From Entering Cells
AUG 24, 2020
Injectable Drug Stops HIV From Entering Cells
Once in the body, HIV tracks down T cells that bear the CD4 receptor. It attaches to these immune cells, fusing itself w ...
SEP 01, 2020
Immunology
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
SEP 01, 2020
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
Malaria is one of the biggest ongoing threats to global health — over 200 million were infected and almost half a ...
SEP 20, 2020
Microbiology
Middle-Aged Adults Might Always be Susceptible to H3N2 Flu
SEP 20, 2020
Middle-Aged Adults Might Always be Susceptible to H3N2 Flu
People born in the late 1960s or 1970s might be perpetually susceptible to the H3N2 influenza virus, according to new re ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
NOV 16, 2020
Immunology
Measles Is Back and COVID Isn't Helping
NOV 16, 2020
Measles Is Back and COVID Isn't Helping
Measles is a highly contagious and airborne viral disease. There is no treatment besides supportive care once a person b ...
Loading Comments...